nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PTGS2—urinary bladder cancer	0.334	1	CbGaD
Niflumic Acid—PLA2G4A—Epirubicin—urinary bladder cancer	0.28	0.554	CbGbCtD
Niflumic Acid—SLC16A1—Methotrexate—urinary bladder cancer	0.101	0.2	CbGbCtD
Niflumic Acid—PTGS2—Cisplatin—urinary bladder cancer	0.044	0.0872	CbGbCtD
Niflumic Acid—PTGS2—Etoposide—urinary bladder cancer	0.0432	0.0857	CbGbCtD
Niflumic Acid—PTGS1—Etoposide—urinary bladder cancer	0.0365	0.0723	CbGbCtD
Niflumic Acid—CLCNKA—renal system—urinary bladder cancer	0.00809	0.119	CbGeAlD
Niflumic Acid—SLC16A7—prostate gland—urinary bladder cancer	0.00395	0.0581	CbGeAlD
Niflumic Acid—PLA2G1B—epithelium—urinary bladder cancer	0.00345	0.0507	CbGeAlD
Niflumic Acid—PLA2G4A—Raltitrexed—Methotrexate—urinary bladder cancer	0.00327	1	CbGdCrCtD
Niflumic Acid—PLA2G1B—renal system—urinary bladder cancer	0.0032	0.0471	CbGeAlD
Niflumic Acid—UGT1A9—renal system—urinary bladder cancer	0.00292	0.043	CbGeAlD
Niflumic Acid—PLA2G4A—prostate gland—urinary bladder cancer	0.00286	0.042	CbGeAlD
Niflumic Acid—SLC16A7—urethra—urinary bladder cancer	0.00265	0.0389	CbGeAlD
Niflumic Acid—PLA2G1B—female reproductive system—urinary bladder cancer	0.00256	0.0377	CbGeAlD
Niflumic Acid—SLC16A1—prostate gland—urinary bladder cancer	0.00252	0.037	CbGeAlD
Niflumic Acid—PLA2G4A—seminal vesicle—urinary bladder cancer	0.00242	0.0356	CbGeAlD
Niflumic Acid—SLC16A7—female reproductive system—urinary bladder cancer	0.00216	0.0317	CbGeAlD
Niflumic Acid—PLA2G4A—smooth muscle tissue—urinary bladder cancer	0.00202	0.0298	CbGeAlD
Niflumic Acid—SLC16A7—vagina—urinary bladder cancer	0.00195	0.0287	CbGeAlD
Niflumic Acid—PLA2G4A—renal system—urinary bladder cancer	0.00195	0.0287	CbGeAlD
Niflumic Acid—PLA2G4A—urethra—urinary bladder cancer	0.00191	0.0281	CbGeAlD
Niflumic Acid—SLC16A1—epithelium—urinary bladder cancer	0.00185	0.0272	CbGeAlD
Niflumic Acid—SLC16A1—renal system—urinary bladder cancer	0.00171	0.0252	CbGeAlD
Niflumic Acid—PLA2G4A—female reproductive system—urinary bladder cancer	0.00156	0.0229	CbGeAlD
Niflumic Acid—PLA2G4A—vagina—urinary bladder cancer	0.00141	0.0208	CbGeAlD
Niflumic Acid—SLC16A1—female reproductive system—urinary bladder cancer	0.00137	0.0202	CbGeAlD
Niflumic Acid—SLC16A7—lymph node—urinary bladder cancer	0.00126	0.0186	CbGeAlD
Niflumic Acid—PTGS1—prostate gland—urinary bladder cancer	0.00113	0.0166	CbGeAlD
Niflumic Acid—Floctafenine—PTGS2—urinary bladder cancer	0.00109	0.719	CrCbGaD
Niflumic Acid—PTGS2—prostate gland—urinary bladder cancer	0.00108	0.0159	CbGeAlD
Niflumic Acid—PTGS1—seminal vesicle—urinary bladder cancer	0.000954	0.014	CbGeAlD
Niflumic Acid—PLA2G4A—lymph node—urinary bladder cancer	0.000912	0.0134	CbGeAlD
Niflumic Acid—PTGS2—seminal vesicle—urinary bladder cancer	0.000912	0.0134	CbGeAlD
Niflumic Acid—PTGS1—epithelium—urinary bladder cancer	0.000829	0.0122	CbGeAlD
Niflumic Acid—SLC16A1—lymph node—urinary bladder cancer	0.000803	0.0118	CbGeAlD
Niflumic Acid—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000799	0.0118	CbGeAlD
Niflumic Acid—PTGS2—epithelium—urinary bladder cancer	0.000793	0.0117	CbGeAlD
Niflumic Acid—PTGS1—renal system—urinary bladder cancer	0.000769	0.0113	CbGeAlD
Niflumic Acid—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000764	0.0112	CbGeAlD
Niflumic Acid—PTGS2—renal system—urinary bladder cancer	0.000735	0.0108	CbGeAlD
Niflumic Acid—PTGS2—urethra—urinary bladder cancer	0.000722	0.0106	CbGeAlD
Niflumic Acid—PTGS1—female reproductive system—urinary bladder cancer	0.000616	0.00906	CbGeAlD
Niflumic Acid—PTGS2—female reproductive system—urinary bladder cancer	0.000589	0.00866	CbGeAlD
Niflumic Acid—PTGS1—vagina—urinary bladder cancer	0.000557	0.0082	CbGeAlD
Niflumic Acid—PTGS2—vagina—urinary bladder cancer	0.000532	0.00783	CbGeAlD
Niflumic Acid—Mefenamic acid—PTGS2—urinary bladder cancer	0.000426	0.281	CrCbGaD
Niflumic Acid—PTGS1—lymph node—urinary bladder cancer	0.00036	0.0053	CbGeAlD
Niflumic Acid—PTGS2—lymph node—urinary bladder cancer	0.000344	0.00507	CbGeAlD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	5.77e-05	0.00065	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	5.77e-05	0.000649	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	5.75e-05	0.000647	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—RRM2—urinary bladder cancer	5.7e-05	0.000642	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.7e-05	0.000642	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—TYMP—urinary bladder cancer	5.68e-05	0.00064	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HDAC4—urinary bladder cancer	5.67e-05	0.000638	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—TYMS—urinary bladder cancer	5.64e-05	0.000635	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	5.62e-05	0.000633	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—NCOR1—urinary bladder cancer	5.58e-05	0.000628	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GSTM1—urinary bladder cancer	5.58e-05	0.000628	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	5.58e-05	0.000628	CbGpPWpGaD
Niflumic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	5.56e-05	0.000626	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—CREBBP—urinary bladder cancer	5.54e-05	0.000624	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	5.54e-05	0.000623	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	5.48e-05	0.000617	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IGF1—urinary bladder cancer	5.47e-05	0.000616	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.46e-05	0.000614	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	5.45e-05	0.000614	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GPX1—urinary bladder cancer	5.34e-05	0.000601	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	5.33e-05	0.0006	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	5.32e-05	0.000599	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	5.31e-05	0.000597	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ENO2—urinary bladder cancer	5.28e-05	0.000595	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—HPGDS—urinary bladder cancer	5.28e-05	0.000595	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ERCC2—urinary bladder cancer	5.24e-05	0.00059	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—PLAU—urinary bladder cancer	5.22e-05	0.000588	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	5.22e-05	0.000587	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.19e-05	0.000585	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	5.18e-05	0.000583	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.15e-05	0.00058	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NAT2—urinary bladder cancer	5.14e-05	0.000579	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTT1—urinary bladder cancer	5.12e-05	0.000577	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.04e-05	0.000567	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTO2—urinary bladder cancer	5.03e-05	0.000566	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NAT1—urinary bladder cancer	5.03e-05	0.000566	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—RHOA—urinary bladder cancer	5.01e-05	0.000564	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	4.98e-05	0.00056	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.95e-05	0.000557	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—MTHFR—urinary bladder cancer	4.93e-05	0.000555	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	4.93e-05	0.000555	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PRSS3—urinary bladder cancer	4.8e-05	0.00054	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.8e-05	0.00054	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GLI1—urinary bladder cancer	4.75e-05	0.000535	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.72e-05	0.000532	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TYMP—urinary bladder cancer	4.71e-05	0.00053	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SLC19A1—urinary bladder cancer	4.67e-05	0.000526	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	4.6e-05	0.000518	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.58e-05	0.000516	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PRSS3—urinary bladder cancer	4.55e-05	0.000512	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	4.53e-05	0.00051	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.52e-05	0.000509	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—RRM2—urinary bladder cancer	4.44e-05	0.000499	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	4.4e-05	0.000495	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HDAC4—urinary bladder cancer	4.34e-05	0.000489	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—CREBBP—urinary bladder cancer	4.31e-05	0.000485	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	4.3e-05	0.000484	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NAT2—urinary bladder cancer	4.26e-05	0.000479	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NQO1—urinary bladder cancer	4.26e-05	0.000479	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IGF1—urinary bladder cancer	4.26e-05	0.000479	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.22e-05	0.000475	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IL2—urinary bladder cancer	4.21e-05	0.000473	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	4.14e-05	0.000466	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ENO2—urinary bladder cancer	4.11e-05	0.000462	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—HPGDS—urinary bladder cancer	4.11e-05	0.000462	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	4.09e-05	0.000461	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.08e-05	0.00046	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PPARG—urinary bladder cancer	4e-05	0.00045	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTT1—urinary bladder cancer	3.98e-05	0.000449	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.92e-05	0.000442	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	3.91e-05	0.00044	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—RHOA—urinary bladder cancer	3.9e-05	0.000439	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.85e-05	0.000433	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CREBBP—urinary bladder cancer	3.84e-05	0.000432	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TYMP—urinary bladder cancer	3.84e-05	0.000432	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PRSS3—urinary bladder cancer	3.81e-05	0.000429	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—EP300—urinary bladder cancer	3.77e-05	0.000425	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.73e-05	0.00042	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.69e-05	0.000415	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—RRM2—urinary bladder cancer	3.68e-05	0.000414	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—SRC—urinary bladder cancer	3.67e-05	0.000413	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	3.61e-05	0.000406	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.61e-05	0.000406	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.6e-05	0.000405	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTP1—urinary bladder cancer	3.55e-05	0.0004	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NAT2—urinary bladder cancer	3.47e-05	0.000391	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—LIG1—urinary bladder cancer	3.45e-05	0.000388	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.43e-05	0.000386	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ENO2—urinary bladder cancer	3.4e-05	0.000383	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—HPGDS—urinary bladder cancer	3.4e-05	0.000383	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.38e-05	0.000381	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.34e-05	0.000376	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NQO1—urinary bladder cancer	3.31e-05	0.000373	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTT1—urinary bladder cancer	3.3e-05	0.000372	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—TYMS—urinary bladder cancer	3.3e-05	0.000372	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IL2—urinary bladder cancer	3.27e-05	0.000368	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NCOR1—urinary bladder cancer	3.26e-05	0.000367	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTM1—urinary bladder cancer	3.26e-05	0.000367	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RBX1—urinary bladder cancer	3.26e-05	0.000367	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.25e-05	0.000366	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.21e-05	0.000362	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTGS2—urinary bladder cancer	3.14e-05	0.000354	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GPX1—urinary bladder cancer	3.13e-05	0.000352	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ERCC2—urinary bladder cancer	3.07e-05	0.000345	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TSC1—urinary bladder cancer	3.06e-05	0.000345	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.06e-05	0.000344	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TYMP—urinary bladder cancer	3.05e-05	0.000343	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—KRAS—urinary bladder cancer	3.04e-05	0.000342	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—RRM2—urinary bladder cancer	3e-05	0.000337	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.99e-05	0.000337	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—EP300—urinary bladder cancer	2.94e-05	0.00033	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.93e-05	0.000329	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.92e-05	0.000329	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—JAG1—urinary bladder cancer	2.91e-05	0.000328	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MTHFR—urinary bladder cancer	2.88e-05	0.000325	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—SRC—urinary bladder cancer	2.85e-05	0.000321	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.8e-05	0.000315	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.79e-05	0.000314	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ENO2—urinary bladder cancer	2.78e-05	0.000312	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—HPGDS—urinary bladder cancer	2.78e-05	0.000312	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.76e-05	0.000311	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTP1—urinary bladder cancer	2.76e-05	0.000311	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.76e-05	0.000311	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NAT2—urinary bladder cancer	2.76e-05	0.00031	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NQO1—urinary bladder cancer	2.74e-05	0.000309	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTEN—urinary bladder cancer	2.74e-05	0.000309	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TP53—urinary bladder cancer	2.7e-05	0.000304	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTT1—urinary bladder cancer	2.69e-05	0.000303	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.67e-05	0.000301	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.66e-05	0.0003	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.65e-05	0.000298	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ENO2—urinary bladder cancer	2.63e-05	0.000296	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—EP300—urinary bladder cancer	2.62e-05	0.000294	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—HRAS—urinary bladder cancer	2.58e-05	0.000291	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—TYMS—urinary bladder cancer	2.57e-05	0.000289	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NCOR1—urinary bladder cancer	2.54e-05	0.000286	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTM1—urinary bladder cancer	2.54e-05	0.000286	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RBX1—urinary bladder cancer	2.49e-05	0.000281	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.46e-05	0.000276	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GPX1—urinary bladder cancer	2.43e-05	0.000274	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ERCC2—urinary bladder cancer	2.39e-05	0.000269	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—RRM2—urinary bladder cancer	2.38e-05	0.000268	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—KRAS—urinary bladder cancer	2.36e-05	0.000266	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—S100B—urinary bladder cancer	2.36e-05	0.000266	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PPARG—urinary bladder cancer	2.34e-05	0.000263	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.32e-05	0.000261	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTP1—urinary bladder cancer	2.29e-05	0.000258	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CREBBP—urinary bladder cancer	2.25e-05	0.000253	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MTHFR—urinary bladder cancer	2.24e-05	0.000253	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—RHOA—urinary bladder cancer	2.24e-05	0.000252	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NQO1—urinary bladder cancer	2.24e-05	0.000252	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—JAG1—urinary bladder cancer	2.23e-05	0.000251	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.21e-05	0.000249	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HPGDS—urinary bladder cancer	2.2e-05	0.000248	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ENO2—urinary bladder cancer	2.2e-05	0.000248	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.19e-05	0.000247	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.17e-05	0.000244	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTT1—urinary bladder cancer	2.14e-05	0.000241	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TYMS—urinary bladder cancer	2.13e-05	0.00024	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NCOR1—urinary bladder cancer	2.12e-05	0.000239	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.1e-05	0.000237	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTM1—urinary bladder cancer	2.1e-05	0.000237	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NCOR1—urinary bladder cancer	2.1e-05	0.000237	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TP53—urinary bladder cancer	2.1e-05	0.000236	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GPX1—urinary bladder cancer	2.01e-05	0.000227	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—HRAS—urinary bladder cancer	2.01e-05	0.000226	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ERCC2—urinary bladder cancer	1.98e-05	0.000223	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL8—urinary bladder cancer	1.96e-05	0.000221	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.89e-05	0.000213	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL2—urinary bladder cancer	1.88e-05	0.000211	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TERT—urinary bladder cancer	1.87e-05	0.000211	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTP1—urinary bladder cancer	1.87e-05	0.00021	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—urinary bladder cancer	1.86e-05	0.000209	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS2—urinary bladder cancer	1.84e-05	0.000207	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PPARG—urinary bladder cancer	1.82e-05	0.000205	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.8e-05	0.000203	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.78e-05	0.0002	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CREBBP—urinary bladder cancer	1.75e-05	0.000197	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TYMS—urinary bladder cancer	1.73e-05	0.000195	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FGFR3—urinary bladder cancer	1.72e-05	0.000193	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTM1—urinary bladder cancer	1.71e-05	0.000193	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NCOR1—urinary bladder cancer	1.71e-05	0.000193	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ESR1—urinary bladder cancer	1.67e-05	0.000188	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GPX1—urinary bladder cancer	1.64e-05	0.000185	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NCOR1—urinary bladder cancer	1.63e-05	0.000183	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.61e-05	0.000181	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTEN—urinary bladder cancer	1.6e-05	0.000181	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—EP300—urinary bladder cancer	1.53e-05	0.000172	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ERCC2—urinary bladder cancer	1.53e-05	0.000172	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.52e-05	0.000171	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPARG—urinary bladder cancer	1.51e-05	0.00017	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.5e-05	0.000169	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.48e-05	0.000167	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CREBBP—urinary bladder cancer	1.46e-05	0.000164	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CREBBP—urinary bladder cancer	1.45e-05	0.000163	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF1—urinary bladder cancer	1.44e-05	0.000162	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—urinary bladder cancer	1.44e-05	0.000162	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—EGFR—urinary bladder cancer	1.44e-05	0.000162	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.43e-05	0.000161	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TERT—urinary bladder cancer	1.43e-05	0.000161	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS2—urinary bladder cancer	1.43e-05	0.000161	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.38e-05	0.000155	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.36e-05	0.000153	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.36e-05	0.000153	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—KRAS—urinary bladder cancer	1.36e-05	0.000153	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RHOA—urinary bladder cancer	1.32e-05	0.000149	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—FGFR3—urinary bladder cancer	1.31e-05	0.000148	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.3e-05	0.000147	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.28e-05	0.000144	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTEN—urinary bladder cancer	1.25e-05	0.00014	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.23e-05	0.000138	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ERBB2—urinary bladder cancer	1.22e-05	0.000138	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.2e-05	0.000135	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—EP300—urinary bladder cancer	1.19e-05	0.000134	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS2—urinary bladder cancer	1.19e-05	0.000133	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.18e-05	0.000133	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL8—urinary bladder cancer	1.16e-05	0.000131	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HRAS—urinary bladder cancer	1.15e-05	0.00013	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CREBBP—urinary bladder cancer	1.12e-05	0.000126	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2—urinary bladder cancer	1.11e-05	0.000125	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCND1—urinary bladder cancer	1.08e-05	0.000122	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP9—urinary bladder cancer	1.05e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CDKN1A—urinary bladder cancer	1.05e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTEN—urinary bladder cancer	1.04e-05	0.000117	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTEN—urinary bladder cancer	1.03e-05	0.000116	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RHOA—urinary bladder cancer	1.01e-05	0.000114	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EP300—urinary bladder cancer	9.95e-06	0.000112	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—EP300—urinary bladder cancer	9.86e-06	0.000111	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARG—urinary bladder cancer	9.75e-06	0.00011	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SRC—urinary bladder cancer	9.68e-06	0.000109	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGS2—urinary bladder cancer	9.67e-06	0.000109	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CREBBP—urinary bladder cancer	9.37e-06	0.000105	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ERBB2—urinary bladder cancer	9.37e-06	0.000105	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MYC—urinary bladder cancer	8.67e-06	9.76e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EGFR—urinary bladder cancer	8.48e-06	9.55e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTEN—urinary bladder cancer	8.43e-06	9.49e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—EP300—urinary bladder cancer	8.04e-06	9.05e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—KRAS—urinary bladder cancer	8.01e-06	9.02e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CDKN1A—urinary bladder cancer	8.01e-06	9.01e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PTEN—urinary bladder cancer	7.99e-06	8.99e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EP300—urinary bladder cancer	7.62e-06	8.58e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SRC—urinary bladder cancer	7.41e-06	8.34e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TP53—urinary bladder cancer	7.12e-06	8.02e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HRAS—urinary bladder cancer	6.81e-06	7.67e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PTEN—urinary bladder cancer	6.69e-06	7.53e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MYC—urinary bladder cancer	6.64e-06	7.47e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EGFR—urinary bladder cancer	6.49e-06	7.31e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—EP300—urinary bladder cancer	6.38e-06	7.18e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—KRAS—urinary bladder cancer	6.14e-06	6.91e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HRAS—urinary bladder cancer	5.21e-06	5.87e-05	CbGpPWpGaD
